dievini Hopp BioTech holding GmbH & Co. KG
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Growth
Geographical Focus
Germany, Italy, Switzerland
Industries Focus
- Healthcare
- Biotechnology
Investor Details Founded: 2005
An active investor in innovative biotechnology companies, focusing on therapeutics and diagnostics for life-threatening diseases.
The firm holds investments in nine companies across Germany, Switzerland, and Italy, primarily developing diagnostics, therapeutics, and vaccines targeting serious conditions such as cancer, infections, and neurodegenerative disorders.
Notably, dievini has been a shareholder of CureVac AG since 2005, currently holding approximately 41% of the company's common shares.
Requirements
- Innovative biotechnology companies developing diagnostics, therapeutics, and vaccines for serious diseases
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- CureVac AG
- Apogenix GmbH
- Heidelberg Pharma AG
Mentioned In
-
$49.95
-
$19.95
-
$99.00
Claim this Investor
Are you an official representative of dievini Hopp BioTech holding GmbH & Co. KG?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim